Status:

ACTIVE_NOT_RECRUITING

TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study

Lead Sponsor:

University Medical Center Groningen

Conditions:

Death

Graft Failure

Eligibility:

All Genders

18+ years

Brief Summary

Short-term (1-year) results of renal transplantation are now excellent (over 95%). Long-term (10-year and longer) results are, however, still disappointing. Where most research has focused on immunosu...

Detailed Description

Short-term (1-year) results of renal transplantation are now excellent (over 95%). Long-term (10-year and longer) results are, however, still disappointing. Where most research has focused on immunosu...

Eligibility Criteria

Inclusion

  • More than one year after renal transplantation
  • History of renal transplantation

Exclusion

  • Signs of active infection
  • Signs of active cardiac decompensation
  • Active malignancy other than skin cancer
  • Prognosis \< 1 year

Key Trial Info

Start Date :

August 1 2001

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2031

Estimated Enrollment :

606 Patients enrolled

Trial Details

Trial ID

NCT03272854

Start Date

August 1 2001

End Date

August 1 2031

Last Update

September 6 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.